Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Oct 23, 2023

BUY
$118.07 - $194.18 $472,280 - $776,720
4,000 New
4,000 $473,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $472,280 - $776,720
4,000 New
4,000 $29,000
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $400,512 - $724,443
3,083 New
3,083 $725,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.